UroGen Applauds BCAN's New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence [Yahoo! Finance]
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
UroGen Weighs ENVISION Success And Expanded Loan In Bladder Cancer Push [Yahoo! Finance]
UroGen: ZUSDURI Poised To Replace TURBT Surgery As SOC In Certain Bladder Cancers [Seeking Alpha]